The effects of serotonergic neurons on glioma cells are mediated by both known (e.g. NLGN3) and previously underappreciated growth factors such as ICAM-1 and NCAM-1, and through activation of the serotonin receptor HTR2A. The gene discussed is NLGN3; the disease is central nervous system cancer.